Journal of Medical Economics' mission is to provide ethical, unbiased and rapid publication of quality content that is validated by rigorous peer review. The aim of Journal of Medical Economics is to serve the information needs of the pharmacoeconomics and healthcare research community, to help translate research advances into patient care and be a leader in transparency/disclosure by facilitating a collaborative and honest approach to publication. Journal of Medical Economics publishes high-quality economic assessments of novel therapeutic and device interventions for an international audience
医学经济学杂志的使命是提供道德，公正和快速出版的高质量的内容，是由严格的同行审查验证。《医学经济学杂志》的宗旨是服务于药物经济学和医疗保健研究界的信息需求，帮助将研究进展转化为患者护理，并通过促进合作和诚实的出版方式成为透明度/披露的领导者。《医学经济学杂志》为国际读者出版高质量的新型治疗和器械干预的经济评估
Comparative financing analysis and political economy of noncommunicable diseases
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1600523
Cost-effectiveness of second-line atezolizumab in Canada for advanced non-small cell lung cancer (NSCLC)
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1590842
Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1609482
Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1614933
Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1569446
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1542599
A discrete-choice experiment to assess treatment modality preferences of patients with depression
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1555404
Treatment patterns and predictors of costs among patients with migraine: evidence from the United States medical expenditure panel survey
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1607358
Costs of administration, travelling, and productivity losses associated with hospital administration of multiple myeloma drugs in Finland
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1569457
Cost-effectiveness of alemtuzumab and natalizumab for relapsing-remitting multiple sclerosis treatment in Iran: decision analysis based on an indirect comparison
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1543189
Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1658591
Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1611587
Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1620752
Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1651122
Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1675417
Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1652184
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1645018
The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1581208
Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1581621
Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1560749
Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1674065
Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: evaluation of a machine learning risk prediction algorithm
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1706543
Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1685818
Cost-effectiveness of sorafenib versus best supportive care in advanced hepatocellular carcinoma in Egypt
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1552432
The economic burden of uncontrolled gout: how controlling gout reduces cost
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1532904
Decrease in American birth rates makes it imperative for the United States to implement state mandated fertility coverage
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1558866
Clinical characteristics, treatment pattern, and medical costs associated with metastatic castration-resistant prostate cancer in Chinese tertiary care hospital settings
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1600524
The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1638789
Cost-effectiveness of rivaroxaban versus apixaban for the initial treatment of venous thromboembolism and extended prevention of recurrences in the UK
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1658589
Current treatment patterns and medical costs for multiple myeloma in Japan: a cross-sectional analysis of a health insurance claims database
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1686870
Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1618862
Federal government-interest patent disclosures for recent top-selling drugs
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1631832
The real-world economic impact of home-based video electroencephalography: the payer perspective
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1636382
A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1649268
Outcomes of transcatheter aortic valve implantation for intermediate-risk patients in Australia: the SOLACE-AU trial
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1663356
Constructing a value-based healthcare system for hypertensive patients through changing payment mode: evidence from a comparative study in rural China
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1558864
Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1669613
Fingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in Iran
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2018.1560750
Healthcare costs and resource utilization in patients with severe aplastic anemia in the US
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1643354
Real-world incidence and burden of adverse events among non-metastatic prostate cancer patients treated with secondary hormonal therapies following androgen deprivation therapy
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1705313
Number needed to treat and cost per remitter for biologic treatments of Crohn’s disease in Japan
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1642900
Retrospective analysis of patients with advanced or metastatic gastric cancer in Colombia
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1617161
Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1663355
Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1576182
Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1705314
Cost-effectiveness of rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation in the Japanese healthcare setting
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1688821
Reoperations in intramedullary fixation of pertrochanteric hip fractures
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1600526
A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1642899
Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1702990
Correction
来源期刊：Journal of Medical EconomicsDOI：10.1080/13696998.2019.1621060
